362703-32-0

Basic information

• Product Name: 4-{[4-(2-methyl-quinolin-4-ylmethoxy)-benzoylamino]-methyl}-tetrahydro-pyran-4-carboxylic acid methyl ester
• Synonyms: 4-{[4-(2-methyl-quinolin-4-ylmethoxy)-benzoylamino]-methyl}-tetrahydro-pyran-4-carboxylic acid methyl ester
• CAS NO: 362703-32-0
• Molecular Weight: 448.519
• Mol File: 362703-32-0.mol

Chemical Properties

• CAS DataBase Reference: 4-{[4-(2-methyl-quinolin-4-ylmethoxy)-benzoylamino]-methyl}-tetrahydro-pyran-4-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-{[4-(2-methyl-quinolin-4-ylmethoxy)-benzoylamino]-methyl}-tetrahydro-pyran-4-carboxylic acid methyl ester(362703-32-0)
• EPA Substance Registry System: 4-{[4-(2-methyl-quinolin-4-ylmethoxy)-benzoylamino]-methyl}-tetrahydro-pyran-4-carboxylic acid methyl ester(362703-32-0)

Safety Data

• Hazardous Substances Data: 362703-32-0(Hazardous Substances Data)

Upstream product

• 362703-30-8 methyl 4-cyanotetrahydro-2H-pyran-4-carboxylate 
• 793658-98-7 4-(aminomethyl)tetrahydropyran-4-carboxylic acid methyl ester 
• 362488-51-5 4-[(2-methyl-4-quinolinyl)methoxy]-benzoic acid 

Relevant articles and documents

Synthesis and structure-activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors

A novel series of achiral TNF-α converting enzyme (TACE) inhibitors has been discovered. These compounds exhibited activities from 0.35 to 11 nM in a porcine TACE assay and inhibited TNF-α production in an LPS-stimulated whole blood assay with an IC5

Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha

The present application describes novel β-amino acid derivatives of formula I: or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, X, Z, Ua, Xa, Ya, Za, R1, R2, R3